PuSH - Publication Server of Helmholtz Zentrum München

24 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Salminen, A.V. et al.: Reply to: A note on rotigotine for restless legs syndrome after renal transplantation. Mov. Disord. 34, 152-153 (2019)
2.
Salminen, A.V. et al.: Reply to: Safety of dopamine agonists for treating restless legs syndrome. Mov. Disord. 34, 150-151 (2019)
3.
Bartl, M.* ; Winkelmann, J. ; Högl, B.* ; Paulus, W.* & Trenkwalder, C.*: Frequent neurological diseases associated with the restless legs syndrome. Nervenarzt 89, 1156-1164 (2018)
4.
Ouled Amar Bencheikh, B.* et al.: LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder. Parkinsonism Relat. Disord. 52, 98-101 (2018)
5.
Trenkwalder, C.* et al.: Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 17, 994-1005 (2018)
6.
Schormair, B. et al.: Identification of novel risk loci for restless legs syndrome: A meta-analysis of genome-wide association studies in individuals of European ancestry: A meta-analysis. Lancet Neurol. 16, 898–907 (2017)
7.
García-Borreguero, D.* et al.: Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: A combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 21, 1-11 (2016)
8.
Trenkwalder, C.* ; Allen, R.P.* ; Högl, B.* ; Paulus, W.* & Winkelmann, J.: Restless legs syndrome associated with major diseases: A systematic review and new concept. Neurology 86, 1336-1343 (2016)
9.
Schulte, E.C. et al.: Blood cis-eQTL analysis fails to identify novel association signals among sub-threshold candidates from genome-wide association studies in restless legs syndrome. PLoS ONE 9:e98092 (2014)
10.
Schulte, E.C. et al.: Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome. Am. J. Hum. Genet. 95, 85-95 (2014)
11.
Faraco, J.* et al.: ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 9:e1003270 (2013)
12.
Oexle, K.* et al.: Dilution of candidates: The case of iron-related genes in restless legs syndrome. Eur. J. Hum. Genet. 21, 410-414 (2013)
13.
Trenkwalder, C.* et al.: Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: A double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 12, 1141-1150 (2013)
14.
Kornum, B.R.* et al.: Common variants in P2RY11 are associated with narcolepsy. Nat. Genet. 43, 66-71 (2011)
15.
Winkelmann, J. et al.: Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet. 7:e1002171 (2011)
16.
Hallmayer, J.* et al.: Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 41, 708-711 (2009)
17.
Kemlink, D. et al.: Replication of restless legs syndrome loci in three European populations. J. Med. Genet. 46, 315-318 (2009)
18.
Kemlink, D. et al.: Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics 9, 75-82 (2008)
19.
Schormair, B. et al.: PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat. Genet. 40, 946-948 (2008)
20.
García-Borreguero, D.* et al.: Augmentation as a treatment complication of restless legs syndrome: Concept and management. Mov. Disord. 22, (Suppl.18), 476-484 (2007)